Additional admission of Mainor Ülemiste AS bonds to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Additional admission of Mainor Ülemiste AS bonds to trading on Nasdaq Baltic MTF First North

Tallinn, Estonia, 2015-11-17 16:05 CET (GLOBE NEWSWIRE) --  

The Management Board of NASDAQ OMX Tallinn AS decided today, on November 17, 2015 to approve the application of Mainor Ülemiste AS and to admit their additionally issued 3,000 bonds with nominal value of EUR 1000 to trading on MTF First North operated by NASDAQ OMX Tallinn AS. The first trading day of Mainor Ülemiste AS additionally issued bonds is Wednesday, November 18, 2015. Thus, altogether 5,000 bonds of Mainor Ülemiste AS (ISIN: EE3300110691) will be traded under the trading code MAYB070018A as of tomorrow.

The Certified Adviser of Mainor Ülemiste AS is AS Redgate Capital (until November 30, 2018).

Nasdaq Baltic Issuer Services +372 640 8800 www.nasdaqbaltic.com

Nasdaq Baltic is a common name for exchanges, regulated markets, alternative markets First North operated by Nasdaq companies in the Baltic states, i.e. NASDAQ OMX Tallinn AS, Nasdaq Riga AS and AB NASDAQ OMX Vilnius.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Mavis Discount Tire Launches New Premier Facility in Florida

Updated Category News Views 119

Mavis Discount Tire Launches New Premier Facility in Florida Mavis Discount Tire, known for its superior automotive service and commitment to customer satisfaction, is thrilled to announce the opening of its latest facility. The new store location, situated at 5260 US Hwy 1, is designed to cater to the needs of the Harris Point and nearby community. Expanding Presence and...

Continue Reading
Electra Therapeutics Secures Major Funding for Innovative Cancer Therapies

Updated Category News Views 250

Electra Therapeutics Makes a Significant Funding Leap Electra Therapeutics has recently announced a remarkable $183 million Series C financing round aimed at enhancing its pipeline of innovative therapies designed to tackle immune disorders and various cancers. This substantial funding is not only indicative of the investors' confidence in the company but also emphasizes...

Continue Reading
Transforming Business Culture: A Call for Excellence

Updated Category News Views 92

Transforming Business Culture: A Call for Excellence In today's dynamic corporate landscape, where competition is fierce and expectations are high, settling for mediocrity is not an option. Bestselling author and leadership expert John Rossman has articulated this challenge in his new work, “The Pig, The Lipstick and the Three Pillars of Champions: Reclaiming Your...

Continue Reading
Quantum BioPharma Offers $7 Million Reward for Insider Tips

Updated Category News Views 130

Quantum BioPharma Announces Whistleblower Cash Reward Quantum BioPharma Ltd. (NASDAQ: QNTM) is making significant waves in the biopharmaceutical industry with its innovative strategy designed to combat stock manipulation. The company has launched a whistleblower policy that offers a remarkable cash reward of up to USD $7 million to those who provide concrete evidence...

Continue Reading
Evaxion Biotech Prepares for Upcoming Quarterly Earnings Call

Updated Category News Views 142

Anticipating Evaxion Biotech's Quarterly Earnings Evaxion Biotech (NASDAQ: EVAX) is gearing up to unveil its quarterly earnings report, creating a buzz of anticipation among investors. The company aims to share essential financial details that could influence stock performance and investor sentiment. Expected Earnings Performance Analyst Predictions Analysts predict that...

Continue Reading